Low-dose interleukin-2 in patients with bipolar depression: a phase 2 randomised double-blind placebo-controlled trial

Marion Leboyer; Marianne Foiselle; Nicolas Tchitchek; Ryad Tamouza; Roberta Lorenzon; Jean-Romain Richard; Raphaele Arrouasse; Philippe Le Corvoisier; Katia Le Dudal; Eric Vicaut; Pierre Ellul; Michelle Rosenzwajg; David Klatzmann

doi:10.1101/2024.07.19.24310686

Low-dose interleukin-2 in patients with bipolar depression: a phase 2 randomised double-blind placebo-controlled trial

View ORCID ProfileMarion Leboyer, View ORCID ProfileMarianne Foiselle, View ORCID ProfileNicolas Tchitchek, View ORCID ProfileRyad Tamouza, View ORCID ProfileRoberta Lorenzon, View ORCID ProfileJean-Romain Richard, View ORCID ProfileRaphaele Arrouasse, View ORCID ProfilePhilippe Le Corvoisier, View ORCID ProfileKatia Le Dudal, View ORCID ProfileEric Vicaut, View ORCID ProfilePierre Ellul, View ORCID ProfileMichelle Rosenzwajg, View ORCID ProfileDavid Klatzmann

doi: https://doi.org/10.1101/2024.07.19.24310686

Marion Leboyer

1Université Paris Est Créteil (UPEC), AP-HP, Department of Psychiatry, Hôpital Henri Mondor, DMU IMPACT, FHU ADAPT, INSERM U955, IMRB, Translational NeuroPsychiatry Laboratory, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Marion Leboyer
For correspondence: marion.leboyer@inserm.fr david.klatzmann@sorbonne-universite.fr

Marianne Foiselle

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Marianne Foiselle

Nicolas Tchitchek

2Sorbonne Université, INSERM, UMR_S 959, Immunology-Immunopathology-Immunotherapy (i3); F-75651, Paris, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Nicolas Tchitchek

Ryad Tamouza

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ryad Tamouza

Roberta Lorenzon

2Sorbonne Université, INSERM, UMR_S 959, Immunology-Immunopathology-Immunotherapy (i3); F-75651, Paris, France

3AP-HP, Pitié-Salpêtrière Hospital, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), F-75651, Paris, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Roberta Lorenzon

Jean-Romain Richard

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Jean-Romain Richard

Raphaele Arrouasse

4Inserm, Centre d’Investigation Clinique 1430 et AP-HP, Hôpitaux Universitaires Henri Mondor, Univ Paris Est Creteil, F-94010 Créteil, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Raphaele Arrouasse

Philippe Le Corvoisier

4Inserm, Centre d’Investigation Clinique 1430 et AP-HP, Hôpitaux Universitaires Henri Mondor, Univ Paris Est Creteil, F-94010 Créteil, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Philippe Le Corvoisier

Katia Le Dudal

4Inserm, Centre d’Investigation Clinique 1430 et AP-HP, Hôpitaux Universitaires Henri Mondor, Univ Paris Est Creteil, F-94010 Créteil, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Katia Le Dudal

Eric Vicaut

5AP-HP, Saint Louis/Lariboisière Hospitals, Unité de recherche clinique and Université Paris 7, F-75010, Paris, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Eric Vicaut

Pierre Ellul

2Sorbonne Université, INSERM, UMR_S 959, Immunology-Immunopathology-Immunotherapy (i3); F-75651, Paris, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Pierre Ellul

Michelle Rosenzwajg

2Sorbonne Université, INSERM, UMR_S 959, Immunology-Immunopathology-Immunotherapy (i3); F-75651, Paris, France

3AP-HP, Pitié-Salpêtrière Hospital, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), F-75651, Paris, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Michelle Rosenzwajg

David Klatzmann

2Sorbonne Université, INSERM, UMR_S 959, Immunology-Immunopathology-Immunotherapy (i3); F-75651, Paris, France

3AP-HP, Pitié-Salpêtrière Hospital, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), F-75651, Paris, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for David Klatzmann
For correspondence: marion.leboyer@inserm.fr david.klatzmann@sorbonne-universite.fr

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

All data produced in the present study are available upon reasonable request to the authors

View the discussion thread.

PreviousNext

Posted July 19, 2024.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Low-dose interleukin-2 in patients with bipolar depression: a phase 2 randomised double-blind placebo-controlled trial

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Low-dose interleukin-2 in patients with bipolar depression: a phase 2 randomised double-blind placebo-controlled trial

Marion Leboyer, Marianne Foiselle, Nicolas Tchitchek, Ryad Tamouza, Roberta Lorenzon, Jean-Romain Richard, Raphaele Arrouasse, Philippe Le Corvoisier, Katia Le Dudal, Eric Vicaut, Pierre Ellul, Michelle Rosenzwajg, David Klatzmann

medRxiv 2024.07.19.24310686; doi: https://doi.org/10.1101/2024.07.19.24310686

Share This Article: